FT-002a

N/A

Report date: 2025/01/22 10:49:15
NME

Base Information

Drug NameFT-002a
Drug Alias NameFT-002a
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionIron chelating agents
TargetsUpdating
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNorway
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHBC Immunology Inc
China Registration ClassN/A

Develop Information

Active CompaniesHBC Immunology Inc
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A